Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer

Clinical trial NCT00118040 · COMPLETED

Trial details

NCT number: NCT00118040
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Bladder Carcinoma Stage I Bladder Cancer AJCC v6 and v7 Stage II Bladder Cancer AJCC v6 and v7 Stage III Bladder Cancer AJCC v6 and v7

Start date: 2005-06-24
Primary completion: 2010-08-15
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.